Literature DB >> 9688059

Combined poly(isobutylcyanoacrylate) and cyclodextrins nanoparticles for enhancing the encapsulation of lipophilic drugs.

A Monza da Silveira1, G Ponchel, F Puisieux, D Duchêne.   

Abstract

PURPOSE: The aim of this study was to prepare and characterize nanoparticulate systems constituted of poly(isobutylcyanoacrylate) and cyclodextrins and intended for increasing the loading of the particles with lipophilic substances. Progesterone was used as a model substance.
METHODS: Nanoparticles were prepared by polymerization of isobutylcyanoacrylate in presence of cyclodextrins or progesterone/ hydroxypropyl-beta-cyclodextrin complex. Particle size, zeta potential, cyclodextrin and progesterone loading of the particles were determined.
RESULTS: Nanoparticles could be easily prepared in presence of cyclodextrins. An increase in hydroxypropyl-beta-cyclodextrin concentration resulted in small nanoparticles (less than 50 nm). It was found that large amounts of cyclodextrins remained associated to the particles, resulting in a 50 fold increase in progesterone loading compared to nanoparticles prepared in absence of cyclodextrins.
CONCLUSIONS: The poly(isobutylcyanoacrylate)cyclodextrin nanoparticles were characterized by the presence of many lipophilic sites belonging to the cyclodextrins which were firmly anchored to the structure of the particles. Therefore, this new type of nanoparticles offers probably an opportunity for increasing the loading of nanoparticles with various lipophilic drugs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688059     DOI: 10.1023/a:1011982211632

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  2 in total

1.  Preparation, purification and morphology of polymeric nanoparticles as drug carriers.

Authors:  M C Venier-Julienne; J P Benoît
Journal:  Pharm Acta Helv       Date:  1996-07

2.  Ocular drug delivery of progesterone using nanoparticles.

Authors:  V H Li; R W Wood; J Kreuter; T Harmia; J R Robinson
Journal:  J Microencapsul       Date:  1986 Jul-Sep       Impact factor: 3.142

  2 in total
  3 in total

Review 1.  Cyclodextrins in drug delivery: an updated review.

Authors:  Rajeswari Challa; Alka Ahuja; Javed Ali; R K Khar
Journal:  AAPS PharmSciTech       Date:  2005-10-14       Impact factor: 3.246

2.  Novel 1-indanone Thiosemicarbazone Antiviral Candidates: Aqueous Solubilization and Physical Stabilization by Means of Cyclodextrins.

Authors:  Romina J Glisoni; Diego A Chiappetta; Albertina G Moglioni; Alejandro Sosnik
Journal:  Pharm Res       Date:  2011-10-06       Impact factor: 4.200

3.  Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery.

Authors:  Estefanía Vega; M Antònia Egea; Ana Cristina Calpena; Marta Espina; M Luisa García
Journal:  Int J Nanomedicine       Date:  2012-03-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.